Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease - PubMed (original) (raw)

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

W S Griffin et al. Proc Natl Acad Sci U S A. 1989 Oct.

Abstract

Interleukin 1, an immune response-generated cytokine that stimulates astrocyte proliferation and reactivity (astrogliosis), was present in up to 30 times as many glial cells in tissue sections of brain from patients with Down syndrome and Alzheimer disease compared with age-matched control subjects. Most interleukin 1-immunoreactive glia in Down syndrome and Alzheimer disease were classified as microglia. The number of interleukin 1 immunoreactive neurons did not appear to differ in Down syndrome and Alzheimer disease compared with control brain. Numerous temporal lobe astrocytes in Alzheimer disease and postnatal Down syndrome were intensely interleukin 1-, S-100-, and glial fibrillary acidic protein-immunoreactive and had reactive structure. Interleukin 1 levels in Alzheimer disease temporal lobe homogenates were elevated, as were the levels of S-100 and glial fibrillary acidic protein, two proteins reportedly elevated in reactive astrocytes. These data suggest that increased expression of S-100 in Down syndrome, resulting from duplication of the gene on chromosome 21 that encodes the beta subunit of S-100, may be augmented by elevation of interleukin 1. As a corollary, the astrogliosis in Alzheimer disease may be promoted by elevation of interleukin 1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 - PubMed
    1. Neuropatol Pol. 1986;24(3):365-76 - PubMed
    1. Arch Neurol. 1985 Nov;42(11):1097-105 - PubMed
    1. Biochim Biophys Acta. 1985 Oct 17;842(2-3):146-50 - PubMed
    1. Lymphokine Res. 1986 Spring;5(2):77-85 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources